Literature DB >> 15106798

Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension.

Robert H Fagard1, Jan A Staessen, Lutgarde Thijs, Christopher J Bulpitt, Denis Clement, Peter W de Leeuw, Matti Jääskivi, Giuseppe Mancia, Eoin O'Brien, Paolo Palatini, Jaakko Tuomilehto, John Webster.   

Abstract

BACKGROUND: Patients with elevated clinic blood pressure and normal ambulatory blood pressure have a better prognosis than patients with sustained ambulatory hypertension, and may not have to be treated with antihypertensive drugs. On the contrary, current guidelines emphasize repeated clinic blood pressure measurements for the initiation of antihypertensive therapy.
OBJECTIVE: To examine the relationship between ambulatory blood pressure at baseline and clinic blood pressure after 6 months of follow-up in untreated hypertensive patients, and the relationships of these pressures with the subsequent incidence of cardiovascular events.
METHODS: Patients who were > or = 60 years old, with systolic clinic blood pressure of 160-219 mmHg and diastolic pressure < 95 mmHg, participated in the Systolic Hypertension in Europe trial. The relationship between ambulatory blood pressure at baseline and clinic blood pressure after 6 months of follow-up was examined in 295 patients enrolled in the Ambulatory Blood Pressure Monitoring substudy and randomized to the placebo arm, and who were still on double-blind treatment and not taking other antihypertensive drugs after 6 months follow-up.
RESULTS: Age averaged 70 +/- 6 years, 41% were men, and baseline daytime ambulatory blood pressure was 152 +/- 16/84 +/- 10 mmHg; clinic blood pressure decreased from 173 +/- 10/86 +/- 6 mmHg at baseline to 163 +/- 20/85 +/- 9 mmHg at month 6. Systolic daytime ambulatory blood pressure at baseline and systolic clinic blood pressure at month 6 were considered normal if < 140 mmHg. Of the 74 patients with normal systolic daytime ambulatory blood pressure at baseline, only seven (9.5%) had a normal systolic clinic blood pressure during follow-up. Conversely, of the 24 patients with normal follow-up clinic blood pressure, only seven (29%) had a normal systolic daytime ambulatory blood pressure at baseline. The incidence of cardiovascular events beyond the 6-month visit was significantly related to baseline ambulatory blood pressure but not to follow-up clinic pressure.
CONCLUSIONS: Baseline daytime ambulatory blood pressure and follow-up clinic blood pressure do not identify the same patients for antihypertensive treatment. Baseline ambulatory pressure is a better predictor of cardiovascular events than follow-up clinic pressure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106798     DOI: 10.1097/00004872-200401000-00016

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Are there benefits of antihypertensive therapy beyond blood pressure lowering?

Authors:  Joseph L Izzo
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

Review 2.  White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty.

Authors:  Mehran Abolbashari
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

Review 3.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

4.  Does reducing physician uncertainty improve hypertension control?: rationale and methods.

Authors:  Valory N Pavlik; Anthony J Greisinger; James Pool; Paul Haidet; David J Hyman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-05

5.  Relationship of 24-hour ambulatory blood pressure and heart rate with markers of hepatic function in cirrhotic patients.

Authors:  Dimitris G Tzamouranis; Alexandra Alexopoulou; Spyros P Dourakis; George S Stergiou
Journal:  BMC Gastroenterol       Date:  2010-12-12       Impact factor: 3.067

6.  Impact of Pediatric Obesity on Diurnal Blood Pressure Assessment and Cardiovascular Risk Markers.

Authors:  Margaret O Murphy; Hong Huang; John A Bauer; Aric Schadler; Majd Makhoul; Jody L Clasey; Aftab S Chishti; Stefan G Kiessling
Journal:  Front Pediatr       Date:  2021-03-04       Impact factor: 3.418

Review 7.  Should white-coat hypertension in diabetes be treated? Pro.

Authors:  Giuseppe Mancia; Roberto Sega; Michele Bombelli; Fosca Quarti-Trevano; Rita Facchetti; Guido Grassi
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.